Expired contract

Radiopharmaceuticals Treatment of Prostate Cancer (Xofigo) 2025

Details

Value
£105,600
Duration
1 year
Topic
Pharmaceutical products
Published
24 January 2025

Tender description

Provision of radiopharmaceuticals for treatment of prostate cancer - Xofigo. Additional information: Below threshold Direct Award. Bayer PLC are the only supplier of Xofigo and no alternative products are on the market.

Timeline

  1. Completed: Award date1 January 2025
  2. Completed: Award published24 January 2025
    Current notice
  3. Completed: Contract expiry date31 December 2025

About the buyer

United Lincolnshire Teaching Hospitals NHS Trust is a healthcare trust running hospitals in Lincoln, Grantham, Boston and Louth. The procurement department supports every division, ward and department. Procurement is the first point of contact for current and prospective suppliers. Clinical procurement specialists work with NHS Supply Chain on standardised item lists.

Over the past 5 years, most of United Lincolnshire Teaching Hospitals NHS Trust's contract awards have been in construction work, medical equipment and pharmaceuticals and repair and maintenance.

AI insights

  • Will the buyer buy this again?
  • Is the winner their go-to supplier?
  • How much has the buyer spent on this?
  • What did the buyer look for last time?

Free, no account needed

Get to the next one first

This contract's been awarded. We'll find a buyer that plans to buy what you sell, before any tender is published.

Find my next tender early
Save in app

Decision makers

Connect with the people behind this procurement.

Contact nameJob titlePhone numberWork email
Head of Procurement+44 •••• ••••••
Commercial Director+44 •••• ••••••
Procurement Manager+44 •••• ••••••
Category Lead+44 •••• ••••••
Senior Buyer+44 •••• ••••••
Contracts Manager+44 •••• ••••••

Finding public sector work shouldn't be hard

Make your next tender search effortless with Stotles. Set up alerts, find decision maker contacts and never miss a good-fit opportunity again.